vip924
vincerx pharma
['vip924', 'vincerx']
$vinc vincerx pharma presents preclinical data on vip924, a first-in-class antibody-drug conjugate (adc), at the 2023 american association for cancer research (aacr) annual meeting 45 seconds delayed.
Democratizing insights.

Not investment advice.